An ALK-Positive Anaplastic Large Cell Lymphoma with Striking Cutaneous Manifestations and Diagnostic Insights

Journal Title: Journal of Dermatology Research - Year 2025, Vol 6, Issue 1

Abstract

Introduction: Secondary Cutaneous Lymphomas (SCL) result from nodal or extranodal lymphoma dissemination and are characterized by skin infiltration. Diagnosing SCL is complex and requires clinical, histopathological and molecular evaluations. SCL can present with diverse manifestations, with disseminated lesions indicating a poor prognosis. This report describes a rare case of ALK-positive Anaplastic Large Cell Lymphoma (ALCL) with cutaneous involvement. Case Report: An 18-year-old male presented with an eight-month history of a tumoral lesion with serohematic crusts on the anterior thoracic region and satellite erythematous-violaceous nodules. No systemic B symptoms were reported. Histopathology revealed a diffuse proliferation of large pleomorphic lymphoid cells in the dermis and hypodermis. Immunohistochemistry showed strong positivity for CD30, EMA and ALK, supporting the diagnosis of secondary cutaneous involvement by ALK-positive nodal/systemic ALCL. Bone marrow biopsy confirmed lymphoma infiltration. The patient was referred for surgical and hematological evaluation and initiated chemotherapy protocols. Discussion: SCL accounts for up to 50% of cutaneous lymphomas and presents as nodules, plaques or ulcerations. Disseminated lesions within six months of diagnosis reduce survival rates significantly. Accurate differentiation between primary and secondary lymphoproliferative diseases requires imaging, bone marrow biopsy and molecular techniques. Treatment includes chemotherapy, radiotherapy and emerging therapies such as checkpoint inhibitors, CAR-T cells and targeted agents like brentuximab vedotin. ALK-positive ALCL is generally associated with a more favorable prognosis compared to ALK-negative subtypes. Conclusion: Early diagnosis and intervention are critical for improving survival in SCL patients. Dermatologists play a crucial role in recognizing these lesions and initiating multidisciplinary management.

Authors and Affiliations

Patrícia Imai Zanardi1*, Carolina Ferreira Baldecerra1, Daiane de Souza1, Fernanda Diacópulos Silva1, Silvio Cesar Franco Giovanni Filho2, Cássio Rafael Moreira3

Keywords

Related Articles

A Case of Pseudochromohidrosis Cured with Oral Erythromycin and Topical Clindamycin

Apocrine chromohidrosis and eccrine pseudochromohidrosis are both rare skin presentations. In case of former patient presents with coloured sweats in apocrine distributions usually axilla, breast etc., while later pres...

Synergistic antiaging and Dermal Restorative Effects of an Oral Bioactive Procollagen and Astaxanthin Supplement with A Topical Retinyl Palmitate, Vitamin C, Hyaluronic Acid and Alpha Hidroxy Acid Based Regimen

Aging is a natural process undergone by every organism, with progressive changes that lead to an impairment of many biological processes. The human skin ages through several mechanisms which may cause changes to the mo...

Exogenous Ochronosis in Facial Lichen Planus Pigmentosus

Lichen planus pigmentosus is a chronic inflammatory pigmentary dermatosis considered a rare variant of the cutaneous lichen planus. It is characterized by acquired dark brown to gray macular pigmentation involving sun-...

Efficacy and Safety of Topical Versus Systemic Isotretinoin for Acne Vulgaris Treatment: A Systematic Review

Introduction: Oral Isotretinoin has been used for years to successfully treat and manage severe acne. Topical isotretinoin has also been used to manage acne. However there exist very few studies that assess the safety an...

Perspectives on the FDA’s Sunscreen Policy: New Aging Theory, Sunlight Benefits, Enhanced Immunity, COVID-19 Mortality, Modelling Analyses, Melanoma Risks and Etiology

Currently, the U.S. Food and Drug Administration’s policy on sunscreens assumes that exposure to sunlight, mainly ultraviolet (UV) rays, damages the skin, the damage is cumulative and any sun exposure should be avoided...

Download PDF file
  • EP ID EP760089
  • DOI https://doi.org/10.46889/JDR.2025.6108
  • Views 21
  • Downloads 0

How To Cite

Patrícia Imai Zanardi1*, Carolina Ferreira Baldecerra1, Daiane de Souza1, Fernanda Diacópulos Silva1, Silvio Cesar Franco Giovanni Filho2, Cássio Rafael Moreira3 (2025). An ALK-Positive Anaplastic Large Cell Lymphoma with Striking Cutaneous Manifestations and Diagnostic Insights. Journal of Dermatology Research, 6(1), -. https://europub.co.uk./articles/-A-760089